HKSE · 2393.HK · HKD
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 06:38 AM UTC. Cached market data; not a live quote.
One-year closing-price history · HKD. Historical prices are not a forecast.
Yestar Healthcare Holdings Company Limited’s quoted price sits in the lower half of its reported 52-week range, 53.68% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Yestar Healthcare Holdings Company Limited’s forward annual dividend is HK$0.06 per share, paid annual. The forward yield is 87.3% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Yestar Healthcare Holdings Company Limited’s next earnings report is currently expected on Mar 26, 2027. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Yestar Healthcare Holdings Company Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Yestar Healthcare Holdings Company Limited, an investment holding company, manufactures, distributes, and sells medical imaging products in Mainland China. The company operates in two segments, Imaging Printing Products, and Medical Products and Equipment. The Imaging Printing Products segment manufactures and sells color photographic paper and industrial NDT x-ray films and PWB films, as well as trades in imaging equipment. The Medical Products and Equipment segment manufactures and sells medical dry, medical wet, and dental films, as well as sells medical equipment and diagnostic reagents. The company also engages in the management of supply chain and service of freight transportation equipment, as well as development of biotechnology. The company was formerly known as Yestar International Holdings Company Limited and changed its name to Yestar Healthcare Holdings Company Limited in January 2017. Yestar Healthcare Holdings Company Limited was founded in 1971 and is headquartered in Shanghai, the People’s Republic of China.
Latest available per-share figures in HKD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 09:36 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q4 2022 | Mar 31, 2023 | -HK$0.40 | HK$2.65B-47.97% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
HK$1.57-HK$0.01 (-0.32%)
Mediwelcome Healthcare Management & Technology Inc.’s quoted price sits in the lower half of its reported 52-week range, 30.84% below the high.
HK$0.26HK$0.00 (0.0%)
China Health Group Limited’s quoted price sits in the lower half of its reported 52-week range, 69.77% below the high.
HK$0.76+HK$0.01 (+0.66%)
Human Health Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 14.61% below the high.
HK$0.38-HK$0.01 (-2.6%)
Kingworld Medicines Group Limited’s quoted price sits in the lower half of its reported 52-week range, 51.92% below the high.
HK$0.57HK$0.00 (0.0%)
Arts Optical International Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 48.18% below the high.
HK$0.25+HK$0.00 (+0.82%)
Tycoon Group Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 36.36% below the high.
HK$0.17-HK$0.00 (-1.15%)
Rainmed Medical Limited’s quoted price sits in the lower half of its reported 52-week range, 47.88% below the high.
HK$0.09HK$0.00 (0.0%)
Tianda Pharmaceuticals Limited’s quoted price sits in the lower half of its reported 52-week range, 35.97% below the high.
